NYSEArca - Delayed Quote
USD
ALPS Medical Breakthroughs ETF (SBIO)
55.78
+2.95
(+5.58%)
At close: 4:00:00 PM EST
Trade SBIO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreETF Summary
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
ETF Overview
| Category | Health |
|---|---|
| Fund Family | ALPS |
| Net Assets | 183.93M |
| YTD Daily Total Return | 8.96% |
| Yield | 0.00% |
| Legal Type | Exchange Traded Fund |
ETF Operations
| Attributes | SBIO | Category Average |
|---|---|---|
|
Annual Report Expense Ratio (net)
|
0.50% | 1.00% |
|
Holdings Turnover
|
58.00% | 50.70% |
|
Total Net Assets
|
2,404.16 | 2,404.16 |
Morningstar Style Box
